Great Point Partners LLC Cytom X Therapeutics, Inc. Transaction History

Great Point Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $5.81 Million - $11.1 Million	-1,500,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.32 - $6.43 $2.16 Million - $3.22 Million	500,000 Added 50.0%	1,500,000 $7.64 Million
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $6.33 Million - $9.91 Million	1,000,000 New	1,000,000 $6.33 Million
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $9.49 Million - $12.8 Million	-1,448,604 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.4 - $14.64 $9.69 Million - $19.2 Million	1,308,886 Added 936.81%	1,448,604 $12.1 Million
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $504,381 - $1.2 Million	139,718 New	139,718 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $8.97 Million - $10.9 Million	-959,077 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$9.5 - $19.16 $9.11 Million - $18.4 Million	959,077 New	959,077 $10.3 Million

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.